15 Jun 2018 15:24
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Surendera Tyagi
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Surendera Tyagi |
2 | Reason for the notification | |
a) | Position/status | Chief Scientific Officer and Global Head of R&D |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Market purchase of 1,400 Ordinary Shares by IG Markets Limited for and on behalf of Surendera Tyagi. |
c) | Price(s) and volume(s) | Price(s): £14.00 Volume(s): 1,400 |
d) | Aggregated information | Volume: 1,400 Price: £19,600.00 |
e) | Date of the transaction | 14 June 2018 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Peter SpeirsCompany Secretary, responsible for releasing this announcement+44 (0) 20 7399 2760
Hikma Pharmaceuticals (HIK)